Cargando…
Protease inhibitor-induced nausea and vomiting is attenuated by a peripherally acting, opioid-receptor antagonist in a rat model
BACKGROUND: Protease inhibitors such as ritonavir can cause nausea and vomiting which is the most common reason for discontinuation. Rats react to nauseous and emetic stimuli by increasing their oral intake of non-nutritive substances like kaolin, known as pica behavior. In this study, we evaluated...
Autores principales: | Yuan, Chun-Su, Wang, Chong-Zhi, Mehendale, Sangeeta R, Aung, Han H, Foo, Adela, Israel, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736972/ https://www.ncbi.nlm.nih.gov/pubmed/19698111 http://dx.doi.org/10.1186/1742-6405-6-19 |
Ejemplares similares
-
Scutellaria baicalensis decreases ritonavir-induced nausea
por: Aung, Han, et al.
Publicado: (2005) -
Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients
por: Kong, Lingping, et al.
Publicado: (2023) -
Postoperative nausea and vomiting
por: Moon, Young Eun
Publicado: (2014) -
Peripherally acting opioid receptor antagonists in pediatric patients
por: Nair, Abhijit
Publicado: (2018) -
Methylnaltrexone: Peripherally Acting µ-Opioid Receptor Antagonist
por: Uritsky, Tanya J.
Publicado: (2019)